| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 80.00× | 80.00× | 79.04× | 85.23× | 84.98× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 5.05× | 4.34× | 4.81× | 5.43× | 5.39× | ||
| 1.21× | 1.21× | 1.21× | 1.16× | 1.17× | ||
| 1.28× | 1.28× | 1.36× | 2.66× | 1.15× | ||
| 0.68× | 0.68× | 0.83× | 1.41× | 0.72× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 84.98 | 85.23 | 79.04 | 80.00 | 80.00 | |
| Working Capital Turnover | 5.39 | 5.43 | 4.81 | 4.34 | 5.05 | |
| Asset Turnover | 1.17 | 1.16 | 1.21 | 1.21 | 1.21 | |
| Cash Conversion (CFO/Net Income) | 1.15 | 2.66 | 1.36 | 1.28 | 1.28 | |
| CFO/EBITDA | 0.72 | 1.41 | 0.83 | 0.68 | 0.68 |